A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 15, 2014

Primary Completion Date

May 22, 2014

Study Completion Date

May 22, 2014

Conditions

Healthy Participants

Interventions

DRUG

ACP-196

Participants will receive ACP-196 oral capsule(s) in all parts.

DRUG

Itraconazole

Participants will receive itraconazole 200 mg capsules BID from Days 4 to 8 with meals and then 200 mg capsule QD on Day 9 under fasting state.

Trial Locations (1)

Celerion, Tempe